Differential gene expression of cytokines and neurotrophic factors in nerve and skin of patients with peripheral neuropathies

Journal of Neurology

Volumn 262, Issue 1, 2015, Pages 203-212

  Üçeyler, Nurcan ^a   Riediger, Nadja ^a   Kafke, Waldemar ^a   Sommer, Claudia ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Cytokine; Gene expression; Neurotrophic factor; Peripheral neuropathy; Skin biopsy; Sural nerve biopsy

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CYTOKINE; ERYTHROPOIETIN; ERYTHROPOIETIN RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; NERVE GROWTH FACTOR; NEUROTROPHIC FACTOR; NEUROTROPHIN 3; PROTEIN TYROSINE KINASE A; TUMOR NECROSIS FACTOR;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION PROFILING; HUMAN; HUMAN TISSUE; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PUNCH BIOPSY; SURAL NERVE; COHORT ANALYSIS; COMPLICATION; GENE EXPRESSION; GENETICS; METABOLISM; MIDDLE AGED; NEURALGIA; PATHOLOGY; PHYSIOLOGY; SKIN; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; CYTOKINES; FEMALE; GENE EXPRESSION; HUMANS; MALE; MIDDLE AGED; NERVE GROWTH FACTORS; NEURALGIA; PERIPHERAL NERVOUS SYSTEM DISEASES; SKIN; SURAL NERVE;

EID: 84957942017     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-014-7556-8     Document Type: Article

References (63)

1. Anand P (1996) Neurotrophins and peripheral neuropathy. Philos Trans R Soc Lond B Biol Sci 351:449–454
2. Anand P, Terenghi G, Warner G, Kopelman P, Williams-Chestnut RE, Sinicropi DV (1996) The role of endogenous nerve growth factor in human diabetic neuropathy. Nat Med 2:703–707
3. Asbury AK, Cornblath DR (1990) Assessment of current diagnostic criteria for Guillain–Barre syndrome. Ann Neurol 27(Suppl):S21–S24
4. Ayrignac X, Viala K, Koutlidis RM, Taieb G, Stojkovic T, Musset L, Leger JM, Fournier E, Maisonobe T, Bouche P (2013) Sensory chronic inflammatory demyelinating polyneuropathy: an under-recognized entity? Muscle Nerve 48:727–732
5. Backonja MM, Coe CL, Muller DA, Schell K (2008) Altered cytokine levels in the blood and cerebrospinal fluid of chronic pain patients. J Neuroimmunol 195:157–163
6. Calvo M, Dawes JM, Bennett DL (2012) The role of the immune system in the generation of neuropathic pain. Lancet Neurol 11:629–642
7. Collins MP, Mendell JR, Periquet MI, Sahenk Z, Amato AA, Gronseth GS, Barohn RJ, Jackson CE, Kissel JT (2000) Superficial peroneal nerve/peroneus brevis muscle biopsy in vasculitic neuropathy. Neurology 55:636–643
8. Dalakas MC (2014) Pathogenesis of immune-mediated neuropathies. Biochim Biophys Acta. doi:10.1016/j.bbadis.2014.06.013
9. Dalakas MC (2011) Potential biomarkers for monitoring therapeutic response in patients with CIDP. J Peripher Nerv Syst 16(Suppl 1):63–67
10. Devigili G, Tugnoli V, Penza P, Camozzi F, Lombardi R, Melli G, Broglio L, Granieri E, Lauria G (2008) The diagnostic criteria for small fibre neuropathy: from symptoms to neuropathology. Brain 131:1912–1925
11. Diamond J (1994) Nerve-skin interactions in adult and aged animals. Prog Clin Biol Res 390:21–44
12. Doupis J, Lyons TE, Wu S, Gnardellis C, Dinh T, Veves A (2009) Microvascular reactivity and inflammatory cytokines in painful and painless peripheral diabetic neuropathy. J Clin Endocrinol Metab 94:2157–2163
13. Dyck PJ, Dyck PJB, Engelstad J (2005) Pathological alterations of nerves. In: Dyck PJ, Thomas PK (eds) Peripheral Neuropathy. Elsevier Saunders, Philadelphia, pp 733–829
14. EFNS, PNS JTFot (2010) European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of multifocal motor neuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society–first revision. J Peripher Nerv Syst 15:295–301
15. EFNS, PNS JTFot (2010) European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of paraproteinemic demyelinating neuropathies. Report of a Joint Task Force of the European Federation of Neurological Societies and the Peripheral Nerve Society–first revision. J Peripher Nerv Syst 15:185–195
16. Eftimov F, van Schaik I (2013) Chronic inflammatory demyelinating polyradiculoneuropathy: update on clinical features, phenotypes and treatment options. Curr Opin Neurol 26:496–502
17. Empl M, Renaud S, Erne B, Fuhr P, Straube A, Schaeren-Wiemers N, Steck AJ (2001) TNF-alpha expression in painful and nonpainful neuropathies. Neurology 56:1371–1377
18. Exley AR, Smith N, Winer JB (1994) Tumour necrosis factor-alpha and other cytokines in Guillain–Barre syndrome. J Neurol Neurosurg Psychiatry 57:1118–1120
19. Han RK, Cheng YF, Zhou SS, Guo H, He RD, Chi LJ, Zhang LM (2014) Increased circulating Th17 cell populations and elevated CSF osteopontin and IL-17 concentrations in patients with Guillain–Barre syndrome. J Clin Immunol 34:94–103
20. Hedstrom KL, Murtie JC, Albers K, Calcutt NA, Corfas G (2014) Treating small fiber neuropathy by topical application of a small molecule modulator of ligand-induced GFRalpha/RET receptor signaling. Proc Natl Acad Sci USA 111:2325–2330
21. Herder C, Lankisch M, Ziegler D, Rathmann W, Koenig W, Illig T, Doring A, Thorand B, Holle R, Giani G, Martin S, Meisinger C (2009) Subclinical inflammation and diabetic polyneuropathy: MONICA/KORA Survey F3 (Augsburg, Germany). Diabetes Care 32:680–682
22. Hughes R, Bensa S, Willison H, Van den Bergh P, Comi G, Illa I, Nobile-Orazio E, van Doorn P, Dalakas M, Bojar M, Swan A (2001) Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy. Ann Neurol 50:195–201
23. Hussain G, Rizvi SA, Singhal S, Zubair M, Ahmad J (2013) Serum levels of TNF-alpha in peripheral neuropathy patients and its correlation with nerve conduction velocity in type 2 diabetes mellitus. Diabetes Metab Syndr 7:238–242
24. Kimura J (2001) Electrodiagnosis in diseases of nerve and muscle: principles and practice. Oxford University Press, New York
25. Lacomis D (2002) Small-fiber neuropathy. Muscle Nerve 26:173–188
26. Lauria G, Cornblath DR, Johansson O, McArthur JC, Mellgren SI, Nolano M, Rosenberg N, Sommer C, European Federation of Neurological S (2005) EFNS guidelines on the use of skin biopsy in the diagnosis of peripheral neuropathy. Eur J Neurol 12:747–758
27. Lee G, Xiang Z, Brannagan TH 3rd, Chin RL, Latov N (2010) Differential gene expression in chronic inflammatory demyelinating polyneuropathy (CIDP) skin biopsies. J Neurol Sci 290:115–122
28. Lenz M, Üçeyler N, Frettlöh J, Hoffken O, Krumova EK, Lissek S, Reinersmann A, Sommer C, Stude P, Waaga-Gasser AM, Tegenthoff M, Maier C (2013) Local cytokine changes in complex regional pain syndrome type I (CRPS I) resolve after 6 months. Pain 154:2142–2149
29. Lewis RA, Sumner AJ, Brown MJ, Asbury AK (1982) Multifocal demyelinating neuropathy with persistent conduction block. Neurology 32:958–964
30. Li S, Jin T, Zhang HL, Yu H, Meng F, Concha Quezada H, Zhu J (2014) Circulating Th17, Th22, and Th1 cells are elevated in the Guillain–Barre syndrome and downregulated by IVIg treatments. Mediators Inflamm 2014:740947
31. Li S, Yu M, Li H, Zhang H, Jiang Y (2012) IL-17 and IL-22 in cerebrospinal fluid and plasma are elevated in Guillain–Barre syndrome. Mediators Inflamm 2012:260473
32. Liang SL, Wang WZ, Huang S, Wang XK, Zhang S, Wu Y (2012) Th17 helper cell and T-cell immunoglobulin and mucin domain 3 involvement in Guillain–Barre syndrome. Immunopharmacol Immunotoxicol 34:1039–1046
33. Lindenlaub T, Sommer C (2003) Cytokines in sural nerve biopsies from inflammatory and non-inflammatory neuropathies. Acta Neuropathol (Berl) 105:593–602
34. Ludwig J, Binder A, Steinmann J, Wasner G, Baron R (2008) Cytokine expression in serum and cerebrospinal fluid in non-inflammatory polyneuropathies. J Neurol Neurosurg Psychiatry 79:1268–1273
35. Maimone D, Annunziata P, Simone IL, Livrea P, Guazzi GC (1993) Interleukin-6 levels in the cerebrospinal fluid and serum of patients with Guillain–Barre syndrome and chronic inflammatory demyelinating polyradiculoneuropathy. J Neuroimmunol 47:55–61
36. Massaro AR, Soranzo C, Carnevale A (1997) Cerebrospinal-fluid ciliary neurotrophic factor in neurological patients. Eur Neurol 37:243–246
37. Mathey EK, Pollard JD, Armati PJ (1999) TNF alpha, IFN gamma and IL-2 mRNA expression in CIDP sural nerve biopsies. J Neurol Sci 163:47–52
38. Mausberg AK, Dorok M, Stettner M, Muller M, Hartung HP, Dehmel T, Warnke C, Meyer Zu, Horste G, Kieseier BC (2013) Recovery of the T-cell repertoire in CIDP by IV immunoglobulins. Neurology 80:296–303
39. Misawa S, Kuwabara S, Mori M, Kawaguchi N, Yoshiyama Y, Hattori T (2001) Serum levels of tumor necrosis factor-alpha in chronic inflammatory demyelinating polyneuropathy. Neurology 56:666–669
40. Murakami T, Kanchiku T, Suzuki H, Imajo Y, Yoshida Y, Nomura H, Cui D, Ishikawa T, Ikeda E, Taguchi T (2013) Anti-interleukin-6 receptor antibody reduces neuropathic pain following spinal cord injury in mice. Exp Ther Med 6:1194–1198
41. Nobile-Orazio E (2014) Chronic inflammatory demyelinating polyradiculoneuropathy and variants: where we are and where we should go. J Peripher Nerv Syst 19:2–13
42. Ohtori S, Miyagi M, Eguchi Y, Inoue G, Orita S, Ochiai N, Kishida S, Kuniyoshi K, Nakamura J, Aoki Y, Ishikawa T, Arai G, Kamoda H, Suzuki M, Takaso M, Furuya T, Kubota G, Sakuma Y, Oikawa Y, Toyone T, Takahashi K (2012) Efficacy of epidural administration of anti-interleukin-6 receptor antibody onto spinal nerve for treatment of sciatica. Eur Spine J 21:2079–2084
43. Opree A, Kress M (2000) Involvement of the proinflammatory cytokines tumor necrosis factor-alpha, IL-1 beta, and IL-6 but not IL-8 in the development of heat hyperalgesia: effects on heat-evoked calcitonin gene-related peptide release from rat skin. J Neurosci 20:6289–6293
44. Puttini S, Panaite PA, Mermod N, Renaud S, Steck AJ, Kuntzer T (2014) Gene expression changes in chronic inflammatory demyelinating polyneuropathy skin biopsies. J Neuroimmunol 270:61–66
45. Puttini S, Panaite PA, Mermod N, Renaud S, Steck AJ, Kuntzer T (2014) Gene expression changes in chronic inflammatory demyelinating polyneuropathy skin biopsies. J Neuroimmunol 270(1–2):61–66
46. Putzu GA, Figarella-Branger D, Bouvier-Labit C, Liprandi A, Bianco N, Pellissier JF (2000) Immunohistochemical localization of cytokines, C5b-9 and ICAM-1 in peripheral nerve of Guillain–Barre syndrome. J Neurol Sci 174:16–21
47. Renaud S, Hays AP, Brannagan TH 3rd, Sander HW, Edgar M, Weimer LH, Olarte MR, Dalakas MC, Xiang Z, Danon MJ, Latov N (2005) Gene expression profiling in chronic inflammatory demyelinating polyneuropathy. J Neuroimmunol 159:203–214
48. Rentzos M, Angeli AV, Rombos A, Kyrozis A, Nikolaou C, Zouvelou V, Dimitriou A, Zoga M, Evangelopoulos ME, Tsatsi A, Tsoutsou A, Evdokimidis I (2012) Proinflammatory cytokines in serum and cerebrospinal fluid of CIDP patients. Neurol Res 34:842–846
49. Rinaldi S, Bennett DL (2014) Pathogenic mechanisms in inflammatory and paraproteinaemic peripheral neuropathies. Curr Opin Neurol 27:541–551
50. Satoh J, Yagihashi S, Toyota T (2003) The possible role of tumor necrosis factor-alpha in diabetic polyneuropathy. Exp Diabesity Res 4:65–71
51. Schneider-Hohendorf T, Schwab N, Üçeyler N, Gobel K, Sommer C, Wiendl H (2012) CD8+ T-cell immunity in chronic inflammatory demyelinating polyradiculoneuropathy. Neurology 78:402–408
52. Soderquist RG, Sloane EM, Loram LC, Harrison JA, Dengler EC, Johnson SM, Amer LD, Young CS, Lewis MT, Poole S, Frank MG, Watkins LR, Milligan ED, Mahoney MJ (2010) Release of plasmid DNA-encoding IL-10 from PLGA microparticles facilitates long-term reversal of neuropathic pain following a single intrathecal administration. Pharm Res 27:841–854
53. Sommer C, Toyka K (2011) Nerve biopsy in chronic inflammatory neuropathies: in situ biomarkers. J Peripher Nerv Syst 16(Suppl 1):24–29
54. Steck AJ, Kinter J, Renaud S (2011) Differential gene expression in nerve biopsies of inflammatory neuropathies. J Peripher Nerv Syst 16(Suppl 1):30–33
55. Tu H, Juelich T, Smith EM, Tyring SK, Rady PL, Hughes TK Jr (2003) Evidence for endogenous interleukin-10 during nociception. J Neuroimmunol 139:145–149
56. Üçeyler N, Häuser W, Sommer C (2011) Systematic review with meta-analysis: cytokines in fibromyalgia syndrome. BMC Musculoskelet Disord 12:245
57. Üçeyler N, Kafke W, Riediger N, He L, Necula G, Toyka KV, Sommer C (2010) Elevated proinflammatory cytokine expression in affected skin in small fiber neuropathy. Neurology 74:1806–1813
58. Üçeyler N, Rogausch JP, Toyka KV, Sommer C (2007) Differential expression of cytokines in painful and painless neuropathies. Neurology 69:42–49
59. Üçeyler N, Schäfers M, Sommer C (2009) Mode of action of cytokines on nociceptive neurons. Exp Brain Res 196:67–78
60. Üçeyler N, Sommer C (2008) Status of immune mediators in painful neuropathies. Curr Pain Headache Rep 12:159–164
61. Vrancken AF, Notermans NC, Jansen GH, Wokke JH, Said G (2004) Progressive idiopathic axonal neuropathy–a comparative clinical and histopathological study with vasculitic neuropathy. J Neurol 251:269–278
62. Yamamoto M, Ito Y, Mitsuma N, Hattori N, Sobue G (2003) Pain-related differential expression of NGF, GDNF, IL-6, and their receptors in human vasculitic neuropathies. Intern Med 42:1100–1103
63. Yamamoto M, Ito Y, Mitsuma N, Li M, Hattori N, Sobue G (2001) Pathology-related differential expression regulation of NGF, GDNF, CNTF, and IL-6 mRNAs in human vasculitic neuropathy. Muscle Nerve 24:830–833